MORGAN STANLEY (MS) 99.43 +0.22 (+0.22%)
99.43 +0.22 (+0.22%)
US6174464486 - Common Stock - After market: 99.65 +0.22 (+0.22%)
Buy % Consensus
Analysts have set a mean price target of 96.52. This target is -2.92% below the current price.
MS was analyzed by 36 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MS.
In the previous month the buy percentage consensus was at a similar level.
MS was analyzed by 36 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-02 | Oppenheimer | Maintains | Outperform |
| 2023-01-19 | Credit Suisse | Maintains | Outperform |
| 2023-01-18 | BMO Capital | Maintains | Outperform |
| 2023-01-18 | Oppenheimer | Maintains | Outperform |
| 2023-01-18 | Wells Fargo | Maintains | Equal-Weight |
| 2023-01-18 | Evercore ISI Group | Maintains | Outperform |
| 2023-01-18 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-01-17 | Cfra | Reiterate | Hold |
| 2023-01-10 | Odeon Capital | Upgrade | Sell -> Hold |
| 2023-01-09 | UBS | Maintains | Buy |
| 2023-01-04 | Wolfe Research | Downgrade | Outperform -> Underperform |
| 2023-01-04 | UBS | Downgrade | Buy -> Neutral |
| 2023-01-03 | Barclays | Maintains | Overweight |
| 2022-12-28 | Oppenheimer | Maintains | Outperform |
| 2022-12-20 | Citigroup | Maintains | Buy |
| 2022-12-06 | JP Morgan | Maintains | Overweight |
| 2022-10-18 | BMO Capital | Maintains | Outperform |
| 2022-10-17 | Oppenheimer | Maintains | Outperform |
| 2022-10-17 | Barclays | Maintains | Overweight |
| 2022-10-17 | Citigroup | Maintains | Buy |
| 2022-10-05 | Atlantic Equities | Downgrade | Overweight -> Neutral |
| 2022-10-04 | Goldman Sachs | Maintains | Buy |
| 2022-09-21 | Goldman Sachs | Maintains | Buy |
| 2022-09-21 | Credit Suisse | Maintains | Outperform |
| 2022-09-12 | Deutsche Bank | Maintains | Hold |
| 2022-09-06 | Odeon Capital | Downgrade | Hold -> Sell |
| 2022-07-15 | BMO Capital | Maintains | Outperform |
| 2022-07-15 | Oppenheimer | Maintains | Outperform |
| 2022-07-15 | Barclays | Maintains | Overweight |
| 2022-07-05 | Credit Suisse | Maintains | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA